Deficient nitric oxide signalling impairs skeletal muscle growth and performance: involvement of mitochondrial dysregulation
Clara De Palma,F Morisi,Sarah Pambianco,Emma Assi,Thierry Touvier,Stefania Russo,Cristiana Perrotta,Vanina Romanello,Silvia Carnio,Valentina Cappello,Valentina Cappello,Paolo Pellegrino,Claudia Moscheni,Maria Teresa Bassi,Marco Sandri,Davide Cervia,Davide Cervia,Emilio Clementi +17 more
Reads0
Chats0
TLDR
The results indicate that nNOSμ/NO is required to regulate key homeostatic mechanisms in skeletal muscle, namely mitochondrial bioenergetics and network remodelling, UPRmt and autophagy.Abstract:
Nitric oxide (NO), generated in skeletal muscle mostly by the neuronal NO synthases (nNOSμ), has profound effects on both mitochondrial bioenergetics and muscle development and function. The importance of NO for muscle repair emerges from the observation that nNOS signalling is defective in many genetically diverse skeletal muscle diseases in which muscle repair is dysregulated. How the effects of NO/nNOSμ on mitochondria impact on muscle function, however, has not been investigated yet. In this study we have examined the relationship between the NO system, mitochondrial structure/activity and skeletal muscle phenotype/growth/functions using a mouse model in which nNOSμ is absent. Also, NO-induced effects and the NO pathway were dissected in myogenic precursor cells. We show that nNOSμ deficiency in mouse skeletal muscle leads to altered mitochondrial bioenergetics and network remodelling, and increased mitochondrial unfolded protein response (UPRmt) and autophagy. The absence of nNOSμ is also accompanied by an altered mitochondrial homeostasis in myogenic precursor cells with a decrease in the number of myonuclei per fibre and impaired muscle development at early stages of perinatal growth. No alterations were observed, however, in the overall resting muscle structure, apart from a reduced specific muscle mass and cross sectional areas of the myofibres. Investigating the molecular mechanisms we found that nNOSμ deficiency was associated with an inhibition of the Akt-mammalian target of rapamycin pathway. Concomitantly, the Akt-FoxO3-mitochondrial E3 ubiquitin protein ligase 1 (Mul-1) axis was also dysregulated. In particular, inhibition of nNOS/NO/cyclic guanosine monophosphate (cGMP)/cGMP-dependent-protein kinases induced the transcriptional activity of FoxO3 and increased Mul-1 expression. nNOSμ deficiency was also accompanied by functional changes in muscle with reduced muscle force, decreased resistance to fatigue and increased degeneration/damage post-exercise. Our results indicate that nNOSμ/NO is required to regulate key homeostatic mechanisms in skeletal muscle, namely mitochondrial bioenergetics and network remodelling, UPRmt and autophagy. These events are likely associated with nNOSμ-dependent impairments of muscle fibre growth resulting in a deficit of muscle performance.read more
Citations
More filters
Journal ArticleDOI
Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease.
Valentina Cappello,Laura Marchetti,Paola Parlanti,Paola Parlanti,Silvia Landi,Ilaria Tonazzini,Marco Cecchini,Vincenzo Piazza,Mauro Gemmi +8 more
TL;DR: The data further characterize the ultrastructural analysis of the KD mouse model, and support recent theories of a dying-back mechanism for neuronal degeneration, which is independent of demyelination.
Journal ArticleDOI
Transcription Factor EB Controls Metabolic Flexibility during Exercise
Gelsomina Mansueto,Andrea Armani,Carlo Viscomi,Luca D’Orsi,Rossella De Cegli,Elena V. Polishchuk,Costanza Lamperti,Ivano Di Meo,Vanina Romanello,Silvia Marchet,Pradip K. Saha,Haihong Zong,Haihong Zong,Bert Blaauw,Francesca Solagna,Caterina Tezze,Paolo Grumati,Paolo Bonaldo,Jeffrey E. Pessin,Massimo Zeviani,Marco Sandri,Andrea Ballabio +21 more
TL;DR: It is shown that TFEB controls metabolic flexibility in muscle during exercise and that this action is independent of peroxisome proliferator-activated receptor-γ coactivator1α (PGC1α).
Journal ArticleDOI
Autophagy regulates satellite cell ability to regenerate normal and dystrophic muscles
E Fiacco,F Castagnetti,Vanessa Bianconi,Luca Madaro,M De Bardi,Francesca Nazio,Francesca Nazio,Adele D'Amico,Enrico Bertini,Francesco Cecconi,Pier Lorenzo Puri,Lucia Latella +11 more
TL;DR: Results support the notion that regeneration-associated autophagy contributes to the early compensatory stage of DMD progression, and interventions that extend activation of Autophagy might be beneficial in the treatment of D MD.
Journal ArticleDOI
Dysfunctional autophagy induced by the pro-apoptotic natural compound climacostol in tumour cells
Silvia Zecchini,Francesca Proietti Serafini,Elisabetta Catalani,Matteo Giovarelli,Marco Coazzoli,Ilaria Di Renzo,Clara De Palma,Cristiana Perrotta,Emilio Clementi,Federico Buonanno,Claudio Ortenzi,Enrico Marcantoni,Anna Rita Taddei,Simona Picchietti,Anna Maria Fausto,Davide Cervia +15 more
TL;DR: It is shown that climacostol potently and selectively impairs autophagy in multiple tumour cells that are committed to die by apoptosis, suggesting the efficacy of ciliate bioactive molecules to identify novel lead compounds in drug discovery and development.
Journal ArticleDOI
A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy
Ronald G. Victor,H. Lee Sweeney,Richard S. Finkel,Craig M. McDonald,Barry J. Byrne,Michelle Eagle,Nathalie Goemans,Krista Vandenborne,Alberto Dubrovsky,Haluk Topaloglu,M. Carrie Miceli,Pat Furlong,John Landry,Robert Elashoff,David A. Cox +14 more
TL;DR: This study provides Class I evidence that tadalafil does not slow ambulatory decline in 7- to 14-year-old boys with Duchenne muscular dystrophy and further studies should be considered to confirm the hypothesis-generating upper limb data and to determine whether ambulanceatory decline can be slowed by initiation of tadalAFil before 7 years of age.
References
More filters
Journal ArticleDOI
Analysis of relative gene expression data using real-time quantitative pcr and the 2(-delta delta c(t)) method
TL;DR: The 2-Delta Delta C(T) method as mentioned in this paper was proposed to analyze the relative changes in gene expression from real-time quantitative PCR experiments, and it has been shown to be useful in the analysis of realtime, quantitative PCR data.
Journal ArticleDOI
Nitric oxide synthases: structure, function and inhibition
TL;DR: This review concentrates on advances in nitric oxide synthase (NOS) structure, function and inhibition made in the last seven years, during which time substantial advances have been made in the authors' understanding of this enzyme family.
Journal ArticleDOI
Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy
Marco Sandri,Claudia Sandri,Alexander Gilbert,Carsten Skurk,Elisa Calabria,Anne Picard,Kenneth Walsh,Stefano Schiaffino,Stewart H. Lecker,Alfred L. Goldberg +9 more
TL;DR: It is shown that in cultured myotubes undergoing atrophy, the activity of the PI3K/AKT pathway decreases, leading to activation of Foxo transcription factors and atrogin-1 induction.
Journal ArticleDOI
FoxO3 controls autophagy in skeletal muscle in vivo.
Cristina Mammucari,Giulia Milan,Vanina Romanello,Eva Masiero,Ruediger Rudolf,Paola Del Piccolo,Steven J. Burden,Raffaella Di Lisi,Claudia Sandri,Jinghui Zhao,Alfred L. Goldberg,Stefano Schiaffino,Marco Sandri +12 more
TL;DR: FoxO3 controls the two major systems of protein breakdown in skeletal muscle, the ubiquitin-proteasomal and autophagic/lysosomal pathways, independently and is pointed to as potential therapeutic targets in muscle wasting disorders and other degenerative and neoplastic diseases in which autophagy is involved.
Journal ArticleDOI
During autophagy mitochondria elongate, are spared from degradation and sustain cell viability
TL;DR: It is shown that mitochondrial morphology determines the cellular response to macroautophagy, and regulated changes in mitochondrial morphology determine the fate of the cell during autophagic degradation.